Annual Cash & Cash Equivalents
$23.55 M
-$19.59 M-45.42%
31 December 2023
Summary:
Moleculin Biotech annual cash & cash equivalents is currently $23.55 million, with the most recent change of -$19.59 million (-45.42%) on 31 December 2023. During the last 3 years, it has risen by +$8.38 million (+55.21%). MBRX annual cash & cash equivalents is now -66.79% below its all-time high of $70.90 million, reached on 31 December 2021.MBRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$9.40 M
-$1.44 M-13.28%
30 September 2024
Summary:
Moleculin Biotech quarterly cash and cash equivalents is currently $9.40 million, with the most recent change of -$1.44 million (-13.28%) on 30 September 2024. Over the past year, it has dropped by -$15.17 million (-61.74%). MBRX quarterly cash and cash equivalents is now -89.10% below its all-time high of $86.29 million, reached on 31 March 2021.MBRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MBRX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.4% | -61.7% |
| 3 y3 years | +55.2% | -87.5% |
| 5 y5 years | +230.1% | -39.0% |
MBRX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -66.8% | +55.2% | -87.5% | at low |
| 5 y | 5 years | -66.8% | +230.1% | -89.1% | at low |
| alltime | all time | -66.8% | >+9999.0% | -89.1% | +3521.5% |
Moleculin Biotech Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.40 M(-13.3%) |
| June 2024 | - | $10.85 M(-35.5%) |
| Mar 2024 | - | $16.82 M(-28.6%) |
| Dec 2023 | $23.55 M(-45.4%) | $23.55 M(-4.2%) |
| Sept 2023 | - | $24.58 M(-23.6%) |
| June 2023 | - | $32.17 M(-13.7%) |
| Mar 2023 | - | $37.27 M(-13.6%) |
| Dec 2022 | $43.15 M(-39.1%) | $43.15 M(-14.4%) |
| Sept 2022 | - | $50.39 M(-13.1%) |
| June 2022 | - | $58.00 M(-12.3%) |
| Mar 2022 | - | $66.10 M(-6.8%) |
| Dec 2021 | $70.90 M(+367.3%) | $70.90 M(-5.7%) |
| Sept 2021 | - | $75.18 M(-5.4%) |
| June 2021 | - | $79.51 M(-7.9%) |
| Mar 2021 | - | $86.29 M(+468.7%) |
| Dec 2020 | $15.17 M | $15.17 M(+18.6%) |
| Sept 2020 | - | $12.79 M(-23.5%) |
| June 2020 | - | $16.73 M(+43.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $11.65 M(+8.5%) |
| Dec 2019 | $10.73 M(+50.5%) | $10.73 M(-30.3%) |
| Sept 2019 | - | $15.41 M(-17.6%) |
| June 2019 | - | $18.70 M(+112.9%) |
| Mar 2019 | - | $8.78 M(+23.1%) |
| Dec 2018 | $7.13 M(-7.5%) | $7.13 M(-17.0%) |
| Sept 2018 | - | $8.60 M(-26.6%) |
| June 2018 | - | $11.72 M(-10.6%) |
| Mar 2018 | - | $13.11 M(+70.0%) |
| Dec 2017 | $7.71 M(+54.1%) | $7.71 M(-11.7%) |
| Sept 2017 | - | $8.74 M(-5.8%) |
| June 2017 | - | $9.27 M(+4.4%) |
| Mar 2017 | - | $8.88 M(+77.4%) |
| Dec 2016 | $5.01 M(>+9900.0%) | $5.01 M(-19.0%) |
| Sept 2016 | - | $6.18 M(-14.6%) |
| June 2016 | - | $7.24 M(+2689.6%) |
| Mar 2016 | - | $259.70 K |
| Dec 2015 | $28.10 K | - |
FAQ
- What is Moleculin Biotech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Moleculin Biotech?
- What is Moleculin Biotech annual cash & cash equivalents year-on-year change?
- What is Moleculin Biotech quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Moleculin Biotech?
- What is Moleculin Biotech quarterly cash and cash equivalents year-on-year change?
What is Moleculin Biotech annual cash & cash equivalents?
The current annual cash & cash equivalents of MBRX is $23.55 M
What is the all time high annual cash & cash equivalents for Moleculin Biotech?
Moleculin Biotech all-time high annual cash & cash equivalents is $70.90 M
What is Moleculin Biotech annual cash & cash equivalents year-on-year change?
Over the past year, MBRX annual cash & cash equivalents has changed by -$19.59 M (-45.42%)
What is Moleculin Biotech quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MBRX is $9.40 M
What is the all time high quarterly cash and cash equivalents for Moleculin Biotech?
Moleculin Biotech all-time high quarterly cash and cash equivalents is $86.29 M
What is Moleculin Biotech quarterly cash and cash equivalents year-on-year change?
Over the past year, MBRX quarterly cash and cash equivalents has changed by -$15.17 M (-61.74%)